VIVOS INC Files 2023 Annual Report on Form 10-K

TL;DR

<b>VIVOS INC has submitted its 2023 annual report (10-K), detailing its financial status and business operations.</b>

AI Summary

VIVOS INC (RDGL) filed a Annual Report (10-K) with the SEC on March 18, 2024. VIVOS INC filed its annual report for the fiscal year ending December 31, 2023. The company is classified under SIC code 3841: Surgical & Medical Instruments & Apparatus. VIVOS INC was formerly known as ADVANCED MEDICAL ISOTOPE Corp, with a name change on November 3, 2008. The filing is a Form 10-K, submitted under the Securities Exchange Act of 1934. The company's principal business address is located at 719 Jadwin Avenue, Richland, WA 99352.

Why It Matters

For investors and stakeholders tracking VIVOS INC, this filing contains several important signals. This 10-K filing provides a comprehensive overview of VIVOS INC's financial performance and strategic direction for the fiscal year 2023, crucial for investors assessing the company's health. Understanding the company's historical data, including its former name and industry classification, offers context for its current market position and potential future growth.

Risk Assessment

Risk Level: medium — VIVOS INC shows moderate risk based on this filing. The company's specific financial performance, including revenue, net income, and debt levels, is not detailed in the provided header information, making a precise risk assessment difficult without the full report.

Analyst Insight

Review the full 10-K filing for detailed financial statements, management discussion, and risk factors to make an informed investment decision.

Key Numbers

• 3841 — SIC Code (STANDARD INDUSTRIAL CLASSIFICATION)
• 20081103 — Date of Name Change (FORMER COMPANY)
• 1934 — SEC Act Year (SEC ACT)
• 000-53497 — SEC File Number (SEC FILE NUMBER)
• 24758364 — Film Number (FILM NUMBER)
• 509-736-4000 — Business Phone (BUSINESS PHONE)

Key Players & Entities

• VIVOS INC (company) — FILER
• ADVANCED MEDICAL ISOTOPE Corp (company) — FORMER COMPANY
• 2023-12-31 (date) — CONFORMED PERIOD OF REPORT
• 2024-03-18 (date) — FILED AS OF DATE
• 719 JADWIN AVENUE (address) — BUSINESS ADDRESS
• RICHLAND (location) — BUSINESS ADDRESS CITY
• WA (location) — BUSINESS ADDRESS STATE
• 99352 (postal_code) — BUSINESS ADDRESS ZIP

FAQ

Industry Context

VIVOS INC operates within the Surgical & Medical Instruments & Apparatus industry, a sector focused on the development and manufacturing of medical devices and equipment.

Regulatory Implications

As a publicly traded company, VIVOS INC is subject to the reporting requirements of the Securities Exchange Act of 1934, necessitating regular filings like the 10-K with the SEC.

What Investors Should Do

1. Analyze the full 10-K for detailed financial statements and performance metrics.
2. Investigate the company's business segments and product lines.
3. Assess the risk factors and management's discussion and analysis for potential challenges and opportunities.

Key Dates

• 2023-12-31: Fiscal Year End — End of the reporting period for the 10-K.
• 2024-03-18: Filing Date — Date the 10-K was officially submitted to the SEC.

Year-Over-Year Comparison

This is the initial 10-K filing information available, with no prior filing data provided for comparison.

Key Financial Figures

• $0.001 — ction 12(g) of the Act: Common Stock, $0.001 Par Value Indicate by check mark if t

Filing Documents

• form10-k.htm (10-K) — 1396KB
• ex10-12.htm (EX-10.12) — 157KB
• ex23.htm (EX-23) — 6KB
• ex31-1.htm (EX-31.1) — 12KB
• ex31-2.htm (EX-31.2) — 12KB
• ex32-1.htm (EX-32.1) — 8KB
• form10-k_001.jpg (GRAPHIC) — 4KB
• form10-k_002.jpg (GRAPHIC) — 3KB
• ex23_001.jpg (GRAPHIC) — 3KB
• ex23_002.jpg (GRAPHIC) — 2KB
• 0001493152-24-010256.txt (&nbsp;) — 6072KB
• rdgl-20231231.xsd (EX-101.SCH) — 32KB
• rdgl-20231231_cal.xml (EX-101.CAL) — 37KB
• rdgl-20231231_def.xml (EX-101.DEF) — 186KB
• rdgl-20231231_lab.xml (EX-101.LAB) — 366KB
• rdgl-20231231_pre.xml (EX-101.PRE) — 290KB
• form10-k_htm.xml (XML) — 900KB

Business

Business 3 Item 1A.

Risk Factors

Risk Factors 14 Item 1B. Unresolved Staff Comments 21 Item 1C Cybersecurity 21 Item 2.

Properties

Properties 21 Item 3.

Legal Proceedings

Legal Proceedings 21 Item 4. Mine Safety Disclosures 21 PART II. Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 22 Item 6. [Reserved] 23 Item 7.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 23 Item 7A.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 26 Item 8.

Financial Statements and Supplementary Data

Financial Statements and Supplementary Data 26 Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 26 Item 9A.

Controls and Procedures

Controls and Procedures 27 Item 9B. Other Information 27 Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 27 PART III. Item 10. Directors, Executive Officers and Corporate Governance 28 Item 11.

Executive Compensation

Executive Compensation 31 Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 33 Item 13. Certain Relationships and Related Transactions, and Director Independence 36 Item 14. Principal Accountant Fees and Services 36 PART IV. Item 15. Exhibits and Financial Statement Schedules 37 2 PART I FORWARD LOOKING STATEMENTS Except for statements of historical fact, certain information described in this Annual Report on Form 10-K (" Annual Report ") contains "forward-looking statements" that involve substantial risks and uncertainties. You can identify these statements by forward-looking words such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "should," "will," "would" or similar words. The statements that contain these or similar words should be read carefully because these statements discuss the Company's future expectations, including its expectations of its future results of operations or financial position, or state other "forward-looking" information. Vivos Inc. believes that it is important to communicate its future expectations to its investors. However, there may be events in the future that the Company is not able to accurately predict or to control. Further, the Company urges you to be cautious of the forward-looking market growth, service, products, and licenses. The risk factors in the section captioned "Risk Factors" in Item 1A of the Company's Annual Report, as well as other cautionary language in this Annual Report, describe such risks, uncertainties and events that may cause the Company's actual results and achievements, whether expressed or implied, to differ materially from the expectations the Company describes in its forward-looking statements. The occurrence of any of the events described as risk factors could have a material adverse effect on the

View Full Filing

View this 10-K filing on SEC EDGAR